1. Bruhn, H., Merboldt, K.D., Michaelis, T., Gyngell, M.L., Hänicke, W., Frahm, J., Schauder, P., Brunner, G., Held, K., Fröhlich, J., Häussinger, D., and Ross, B.D. (1991) Proton MRS of metabolic disturbances in the brain of patients with liver cirrhosis and subclinical hepatic encephalopathy.Proc 10th Ann Mtg Soc Magn Reson Med. 1: 400.
2. Brunberg, J.A., Kanal, E., Hirsch, W., and Van Thiel, D.H. (1991) Chronic acquired hepatic failure: MR imaging of the brain at 1.5 T.Am J Neuro Radiol. 12: 909–914
3. Bryant, D.J., Weeks, R.A., Marcus, C.D., Sargentoni, J., Taylor-Robinson, S., and Brooks, D.J. (1994) Glutamate in Huntington's disease.Lancet. 344: 189–190.
4. Butterworth, R.F., Giguere, J.F., Michaud, J., Lavoie, J., and Layrargues, G.P. (1987) Ammonia: key factor in the pathogenesis of hepatic encephalopathy.Neurochem Pathol. 6: 1–12.
5. Chamuleau, R.A., Bosman, D.K., Bovée, W.M.M.J., Luyten, P.R., and den Hollander, J.A. (1991) What the clinician can learn from MR glutamine/glutamate assays.NMR Biomed. 4: 103–108.